Dianthus Therapeutics (DNTH) Non-Current Assets (2017 - 2025)
Historic Non-Current Assets for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $163.6 million.
- Dianthus Therapeutics' Non-Current Assets rose 14509.05% to $163.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.8 million, marking a year-over-year increase of 43967.71%. This contributed to the annual value of $93.1 million for FY2024, which is 466479.02% up from last year.
- Dianthus Therapeutics' Non-Current Assets amounted to $163.6 million in Q3 2025, which was up 14509.05% from $62.5 million recorded in Q2 2025.
- Dianthus Therapeutics' Non-Current Assets' 5-year high stood at $163.6 million during Q3 2025, with a 5-year trough of $1.0 million in Q3 2023.
- In the last 4 years, Dianthus Therapeutics' Non-Current Assets had a median value of $33.1 million in 2022 and averaged $44.0 million.
- Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 9684.94% in 2023, then soared by 651635.28% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Non-Current Assets (Quarter) stood at $1.1 million in 2022, then skyrocketed by 81.43% to $2.0 million in 2023, then skyrocketed by 4664.79% to $93.1 million in 2024, then skyrocketed by 75.74% to $163.6 million in 2025.
- Its Non-Current Assets was $163.6 million in Q3 2025, compared to $62.5 million in Q2 2025 and $77.6 million in Q1 2025.